MedTrace Logo

Post Market Clinical Follow-Up Study Protocol for CONSERVE® Press-Fit Femoral Components

NCT02285842 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 143

Last updated 2023-06-07

No results posted yet for this study

Summary

MicroPort Orthopedics (MPO) is conducting this PMCF study to evaluate the safety and efficacy of its THA and resurfacing components marketed in the EU. These types of studies are required by regulatory authorities for all THA and resurfacing devices that do not have medium to long-term clinical evidence available at the time of gaining approval to market in the EU. This study has been designed in accordance with MEDDEV 2.12/2 rev 2.

Conditions

  • Joint Disease

Interventions

DEVICE

Primary hip resurfacing device

CONSERVE® Press-Fit Femoral Components

Sponsors & Collaborators

  • MicroPort Orthopedics Inc.

    lead INDUSTRY

Principal Investigators

  • Paul Beaule, MD · Ottawa Hospital Research Institute

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2027-12-31
Completion
2028-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02285842 on ClinicalTrials.gov